| |
Number (%)
|
Deaths (%)
|
|---|
|
Time on ART
|
|
0–6 months
|
269,076 (100)
|
6836 (31)
|
|
7–12 months
|
259,734 (97)
|
2062 (9)
|
|
13–24 months
|
252,929 (94)
|
3116 (14)
|
|
25–36 months
|
223,556 (83)
|
2558 (12)
|
|
> 36 months
|
185,632 (69)
|
7177 (33)
|
|
Age (years)
|
|
15–24
|
27,136 (10)
|
1238 (6)
|
|
25–34
|
84,444 (31)
|
5900 (27)
|
|
35–44
|
83,467 (31)
|
7285 (33)
|
|
> 45
|
74,029 (28)
|
7326 (34)
|
|
CD4 cell count (cells per μL)
|
|
< 200
|
87,765 (33)
|
13,946 (66)
|
|
200–349
|
77,229 (29)
|
4685 (22)
|
|
350–499
|
49,911 (19)
|
1750 (8)
|
|
≥ 500
|
54,171 (20)
|
1368 (6)
|
|
Sex
|
|
Male
|
165,643 (62)
|
14,536 (67)
|
|
Female
|
103,433 (38)
|
7213 (33)
|
|
Year of ART initiation
|
|
2006
|
18,056 (7)
|
2530 (12)
|
|
2007
|
21,699 (8)
|
3015 (14)
|
|
2008
|
33,666 (13)
|
4068 (19)
|
|
2009
|
22,111 (8)
|
2710 (12)
|
|
2010
|
22,387 (8)
|
2342 (11)
|
|
2011
|
22,621 (8)
|
1967 (9)
|
|
2012
|
26,968 (10)
|
1911 (8)
|
|
2013
|
29,668 (11)
|
1466 (7)
|
|
2014
|
35,818 (13)
|
1092 (5)
|
|
2015
|
36,082 (13)
|
648 (3)
|
|
Region
|
|
Southeast
|
129,531 (48)
|
9868 (45)
|
|
Central-West
|
17,261 (6)
|
1450 (7)
|
|
Northeast
|
41,684 (15)
|
3327 (15)
|
|
South
|
62,400 (23)
|
5633 (26)
|
|
North
|
18,168 (7)
|
1469 (7)
|
|
missing
|
32 (0.01)
|
2 (0.009)
|
|
Risk group
|
|
Heterosexual male
|
51,069 (19)
|
5552 (26)
|
|
Bisexual male
|
11,244 (4)
|
880 (4)
|
|
MSM
|
36,198 (13)
|
1857 (9)
|
|
Male IDU
|
7393 (3)
|
1401 (6)
|
|
Female non-IDU
|
63,143 (23)
|
4910 (23)
|
|
Female IDU
|
1665 (0.6)
|
294 (1)
|
|
other
|
218 (0.08)
|
28 (0.1)
|
|
missing
|
98,146 (36)
|
6827 (31)
|
|
Total
|
269,076
|
21,749
|
- The percentages in each subgroup refer to the proportion of individuals in each category of the subgroup. The numbers of individuals by time on treatment however, where individuals contribute to multiple periods of treatment time, begin at the total number at baseline (i.e. 100%) and decrease as individuals die / are censored
